Rational Design of a Meningococcal Antigen Inducing Broad Protective Immunity
- 13 July 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (91), 91ra62
- https://doi.org/10.1126/scitranslmed.3002234
Abstract
The sequence variability of protective antigens is a major challenge to the development of vaccines. For Neisseria meningitidis, the bacterial pathogen that causes meningitis, the amino acid sequence of the protective antigen factor H binding protein (fHBP) has more than 300 variations. These sequence differences can be classified into three distinct groups of antigenic variants that do not induce cross-protective immunity. Our goal was to generate a single antigen that would induce immunity against all known sequence variants of N. meningitidis. To achieve this, we rationally designed, expressed, and purified 54 different mutants of fHBP and tested them in mice for the induction of protective immunity. We identified and determined the crystal structure of a lead chimeric antigen that was able to induce high levels of cross-protective antibodies in mice against all variant strains tested. The new fHBP antigen had a conserved backbone that carried an engineered surface containing specificities for all three variant groups. We demonstrate that the structure-based design of multiple immunodominant antigenic surfaces on a single protein scaffold is possible and represents an effective way to create broadly protective vaccines.Keywords
This publication has 27 references indexed in Scilit:
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1Science, 2010
- Review of Meningococcal Group B VaccinesClinical Infectious Diseases, 2010
- Antibodies to the Buried N Terminus of Rhinovirus VP4 Exhibit Cross-Serotypic NeutralizationJournal of Virology, 2009
- Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidisPublished by Elsevier BV ,2009
- Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086Journal of Biological Chemistry, 2009
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydratesNature, 2009
- Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding ProteinInfection and Immunity, 2008
- Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein VaccinesInfection and Immunity, 2008
- Prevalence of Factor H–Binding Protein Variants and NadA among Meningococcal Group B Isolates from the United States: Implications for the Development of a Multicomponent Group B VaccineThe Journal of Infectious Diseases, 2007
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences of the United States of America, 2006